VRDN
VRDN
NASDAQ · Biotechnology

Viridian Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$28.35
+1.16 (+4.27%)
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 22 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +125.2% upside
Low Target $43.31
Average Target $63.84
High Target $68.31
Current Price $28.35
Current
$28.35
Target
$63.84
$43.31 $63.84 avg $68.31
Scenario Analysis
Bear Case
$43.31
52.8%
Low target
Base Case
$63.84
+125.2%
Avg target
Bull Case
$68.31
+141.0%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$34.29
-17.3% from high
52-Week Low
$9.90
+186.4% from low
50-Day SMA
$31.51
-10.0% vs SMA
200-Day SMA
$22.43
+26.4% vs SMA
RSI (14)
17.6
Oversold
Target vs 52W High
$63.84
+86.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%